Nu-3 Gel for Mild Diabetic Foot Infections
Part of Heart & circulation, Hormones & metabolism, Infections, Skin clinical trials.
This study tests a new gel treatment (Nu-3) for mild infections in diabetic foot ulcers. The goal is to find the right dose and see if it helps heal these wounds safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes and a mild foot infection with specific signs (drainage, redness, warmth, pain, swelling, or hardness)
- Your foot ulcer is shallow (only in the top layers of skin), between 1–12 cm² in size, and located on or below your ankle bone
- You have good blood flow to your foot, confirmed by a recent test
- You have someone (a caregiver) who can help apply wound dressing at home or attend clinic visits
- You are not pregnant, not nursing, and willing to use birth control if needed during the study
- You are willing to wear a special pressure-relieving boot if your ulcer is on the bottom of your foot
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new wound-healing product called Miro3D to help diabetic foot ulcers heal better. You would receive this product along with standard wound care to see if it helps your ulcer close faster than standard treatment alone.
This trial tests a special dressing that releases nitric oxide to help heal foot ulcers in people with diabetes. It may be an option if you have a diabetes-related foot sore that is not too deep or infected.
This trial tests a new gel (Nu-3) to treat mild infections in diabetic foot ulcers. If you have diabetes and a small, shallow ulcer on or below your ankle with signs of infection, this treatment might help heal it without needing stronger medications.
This study tests whether a new wound gel helps heal diabetic foot ulcers better than the standard gel. It is for people with mild to moderate foot ulcers who have good blood flow and are not taking certain medications.
This Phase 3 trial tests ENERGI-F703 gel to help heal diabetic foot ulcers that have not improved for at least 4 weeks. It may help some people whose wounds meet specific size and non-infection criteria.
This trial tests a gel containing a light-activated drug (chlorin E6) for diabetic foot ulcers. The gel is applied to the ulcer and then activated with a special light to help the wound heal. It may be a good option if you have a foot ulcer that hasn't healed in 6 weeks or more.
Hear when a new Diabetic Foot Ulcers (DFUs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.